Worldwide TAVI registries: what have we learned?

被引:28
作者
Haussig, Stephan [1 ]
Schuler, Gerhard [1 ]
Linke, Axel [1 ]
机构
[1] Univ Leipzig, Dept Internal Med Cardiol, Ctr Heart, D-04289 Leipzig, Germany
关键词
Aortic Valve Stenosis; Medtronic CoreValve System; Edwards SAPIEN tissue heart valve; Surgical aortic valve replacement; AORTIC-VALVE IMPLANTATION; HIGH-RISK PATIENTS; CORONARY-ARTERY-DISEASE; OUTCOME SOURCE REGISTRY; END-POINT DEFINITIONS; EDWARDS SAPIEN; FOLLOW-UP; PERCUTANEOUS IMPLANTATION; EUROPEAN REGISTRY; SUBCLAVIAN ACCESS;
D O I
10.1007/s00392-014-0698-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With a rapidly aging society, the number of patients with cardiovascular disease-in particular aortic stenosis-is progressively increasing. Although conventional aortic valve replacement remains the only treatment known to improve prognosis and symptoms in symptomatic patients with aortic stenosis, about one-third are still withhold from the life-saving therapy. Based on the compelling evidence of the randomized Placement of Aortic transcatheter valves (PARTNER) A and B cohort, TAVI is now considered standard of care for extreme risk and inoperable patients and is an alternative to surgery for high-risk patients with symptomatic aortic stenosis. However, these patients were super-selected, which does not reflect a clinical real-world situation. TAVI registries represent a real-world scenario, and therefore provide the evidence for the treatment of high-risk patients (regarding comorbidities and anatomical factors) in daily clinical life. The review will focus on the recently published Edwards SAPIEN, Medtronic CoreValve and mixed (national) registries with the focus on short- and midterm outcome. These registries suggest that the growing experience of the operators with regard to patient selection, prevention, recognition and treatment of procedural complications together with the developments in valve design will improve the short-term results of TAVI. However, randomized trials in intermediate risk patients and data on long-term valve durability are a prerequisite before indications can be expanded to younger and lower risk patient population.
引用
收藏
页码:603 / 612
页数:10
相关论文
共 82 条
[1]   Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry [J].
Abdel-Wahab, Mohamed ;
Zahn, Ralf ;
Horack, Martin ;
Gerckens, Ulrich ;
Schuler, Gerhard ;
Sievert, Horst ;
Naber, Christoph ;
Voehringer, Matthias ;
Schaefer, Ulrich ;
Senges, Jochen ;
Richardt, Gert .
CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (12) :973-981
[2]   A case of rotational atherectomy after implantation of the Medtronic CoreValve bioprosthesis [J].
Abdel-Wahab, Mohamed ;
Mostafa, Ahmad E. ;
Richardt, Gert .
CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (07) :595-597
[3]   Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry [J].
Abdel-Wahab, Mohamed ;
Zahn, Ralf ;
Horack, Martin ;
Gerckens, Ulrich ;
Schuler, Gerhard ;
Sievert, Horst ;
Eggebrecht, Holger ;
Senges, Jochen ;
Richardt, Gert .
HEART, 2011, 97 (11) :899-906
[4]   Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation [J].
Akin, I. ;
Kische, S. ;
Schneider, H. ;
Liebold, A. ;
Ortak, J. ;
Baensch, D. ;
Rehders, T. C. ;
Thiele, O. ;
Schneider, R. ;
Kundt, G. ;
Krenz, H. ;
Chatterjee, T. ;
Nienaber, C. A. ;
Ince, H. .
CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (05) :357-364
[5]   Evaluation of Patients With Severe Symptomatic Aortic Stenosis Who Do Not Undergo Aortic Valve Replacement The Potential Role of Subjectively Overestimated Operative Risk [J].
Bach, David S. ;
Siao, Derrick ;
Girard, Steven E. ;
Duvernoy, Claire ;
McCallister, Benjamin D., Jr. ;
Gualano, Sarah K. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (06) :533-539
[6]   The German Aortic Valve Registry (GARY): A Nationwide Registry for Patients Undergoing Invasive Therapy for Severe Aortic Valve Stenosis [J].
Beckmann, A. ;
Hamm, C. ;
Figulla, H. R. ;
Cremer, J. ;
Kuck, K. H. ;
Lange, R. ;
Zahn, R. ;
Sack, S. ;
Schuler, G. C. ;
Walther, T. ;
Beyersdorf, F. ;
Boehm, M. ;
Heusch, G. ;
Funkat, A. K. ;
Meinertz, T. ;
Neumann, T. ;
Papoutsis, K. ;
Schneider, S. ;
Welz, A. ;
Mohr, F. W. .
THORACIC AND CARDIOVASCULAR SURGEON, 2012, 60 (05) :319-325
[7]   The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation? [J].
Beller, Carsten J. ;
Schmack, Bastian ;
Seppelt, Philipp ;
Arif, Rawa ;
Bekeredjian, Raffi ;
Krumsdorf, Ulrike ;
Katus, Hugo A. ;
Karck, Matthias ;
Kallenbach, Klaus .
CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (02) :111-117
[8]   Direct Flow Medical valve [J].
Bijuklic, Klaudija ;
Tuebler, Thilo ;
Low, Reginald I. ;
Grube, Eberhard ;
Schofer, Joachim .
EUROINTERVENTION, 2012, 8 :Q75-Q78
[9]   Early SAPIEN transcatheter heart valve dysfunction due to tissue ingrowth in an octogenarian [J].
Blumenstein, J. ;
Van Linden, A. ;
Kim, W. K. ;
Skwara, W. ;
Schoenburg, M. ;
Arsalan, M. ;
Moellmann, H. ;
Niederhagen, M. ;
Kempfert, J. ;
Walther, T. .
CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (03) :237-240
[10]   Retrograde, transsubclavian implantation of a SAPIEN XT™ aortic valve prosthesis with the Edwards NovaFlex+™ system [J].
Blumenstein, J. ;
Van Linden, A. ;
Kempfert, J. ;
Kim, Woung-Keung ;
Liebetrau, C. ;
Hamm, C. ;
Nef, H. ;
Walther, T. ;
Moellmann, H. .
CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (09) :773-775